AXTA vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 17, 2026

AXTA

57.9
AI Score
VS
AXTA Wins

CBT

54.0
AI Score

Investment Advisor Scores

AXTA

58score
Recommendation
HOLD

CBT

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AXTA CBT Winner
Revenue 1.25B 2.73B CBT
Net Income 90.00M 147.00M CBT
Net Margin 7.2% 5.4% AXTA
Operating Income 146.00M 356.00M CBT
ROE 3.7% 9.2% CBT
ROA 1.2% 3.7% CBT
Total Assets 7.56B 3.98B AXTA
Cash 608.00M 250.00M AXTA
Current Ratio 2.10 1.47 AXTA
Free Cash Flow 18.00M 126.00M CBT

Relative Price Performance (Last 90 Days)

AXTA 1M: +8.1% · 3M: +7.0% CBT 1M: -5.7% · 3M: -17.5%

Current Technical Phase

AXTA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.4 · Price: $35.05

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 38

RSI (14): 37.7 · Price: $74.33

Fundamentals Snapshot

Metric AXTA CBT
Market Cap — —
Forward P/E 12.4 10.6
Trailing P/E 21.5 20.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.2%
Operating Margin 0.2% 0.1%
EPS 1.63 3.57
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, AXTA is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.